Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

46.09 (USD) • At close November 7, 2024
Bedrijfsnaam Amphastar Pharmaceuticals, Inc.
Symbool AMPH
Munteenheid USD
Prijs 46.09
Beurswaarde 2,243,467,622
Dividendpercentage 0%
52-weken bereik 36.56 - 65.92
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Yongfeng Zhang Ph.D.
Website https://www.amphastar.com

An error occurred while fetching data.

Over Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief

Vergelijkbare Aandelen

Bright Green Corporation logo

Bright Green Corporation

BGXX

0.076 USD

Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

RLAY

6.14 USD

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.31 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

18.78 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

96.23 USD

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

17.67 USD

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

4.66 USD

Sage Therapeutics, Inc. logo

Sage Therapeutics, Inc.

SAGE

6.32 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)